Fig. 1From: Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugationAnnotated structure of 4D5scFv. Five selected candidate sites (red), CDR (yellow), His-tag (cyan), and linker (orange)Back to article page